Merck is undergoing a strategic restructuring, resulting in immediate job cuts in administration, sales, and research as part of a plan to save $3 billion by 2027.

Merck’s stock is falling after a rare revenue miss, and the announcement of a $3 billion cost-cutting plan that will include layoffs.

Merck and Co. is slashing $3 billion from its annual spending as it braces for off-brand competition to its cancer drug Keytruda, the best-selling medicine in the world.

MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection ...

Posted 2024-01-22T19:47:52Z - Updated 2024-01-22T20:50:07Z By David Arkin This article was written for our sponsor, North Carolina Biotechnology Center ...

The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.

Merck & Co., Inc. At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world ...

Merck sign outside its plant in Durham (WRAL photo) by Jamie Crockett, NC A&T via N.C. Biotech Center — June 12, 2023 .

DURHAM – North Carolina’s unemployment rate is still hovering near 10 percent, but don’t tell that to pharmaceutical giant Merck & Co. By the end of this year, Merck will grow its Durham ...